We serve Chemical Name:Safflower yellow CAS:1401-20-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Safflower yellow
CAS.NO:1401-20-3
Synonyms:C.I.Natural Yellow 5;Safflower yellow
Molecular Formula:C42H43O22
Molecular Weight:899.78
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like C.I.Natural Yellow 5 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Safflower yellow physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Safflower yellow Use and application,C.I.Natural Yellow 5 technical grade,usp/ep/jp grade.
Related News: The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. Safflower yellow manufacturer The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported. Safflower yellow supplier Eli Lilly and Roche have been riding high this week on the controversial approval of Biogen’s anti-amyloid Alzheimer’s disease drug Aduhelm (aducanumab), as its new low bar could help these Big Pharmas jump the finish line. Safflower yellow vendor This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. Safflower yellow factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.